Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05255562Completed
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital. Primary endpoint: Pain Scores at 48 hours. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05255562.